Abstract
Introduction: Vaccination against COVID-19 is an essential tool in the fight against the pandemic, but adherence to vaccination programmes is a major challenge, particularly in African countries. This study aimed to identify determinants of uptake of the first dose of COVID-19 vaccine using large-scale data collected from the Beninese population. Methods: We conducted a cross-sectional and analytical study using a telephone survey between December 2021 and January 2022. The study covered Beninese aged 18 and over. Marginal quota sampling (n = 858) was used, with age, gender and department as quota variables. The questionnaire was inspired by the Theory of Planned Behaviour and the Health Belief Model. Binary logistic regression was used at the 5% significance level. Results: According to this study, 56.9% of people had received at least one dose of the COVID-19 vaccine. The likelihood of getting the first dose is increased by having confidence in the vaccine (aOR= 2.009; CI= 1.414-2.853), finding the length of waiting time at vaccination centres acceptable (aOR= 1.601; CI= 1.128-2.273), living in the centre of Benin (aOR= 2. 398, IC= 1.461-3.935), not having heard or seen anything bad about the vaccine (aOR= 1.586 IC= 1.444-2.200), and having a high perceived benefit (aOR= 1.57; IC: 1.003-2.458). However, the main barriers to vaccination were never having been vaccinated as an adult (aOR= 0.463; CI: 0.333-0.643), being over 60 (aOR= 0.428; CI: 0.220-0.832), and perceiving the risk of vaccination as high (aOR= 0.669; CI: 0.481-0.931). Conclusions: This study has provided results that can guide decision-makers in epidemic response programmes against COVID-19 and other similar pandemics Vaccination coverage is not negligible, but efforts are still needed, particularly in the south, among the elderly and people without previous vaccination experience. It is also important to improve confidence in the vaccine and to combat misinformation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the French Development Agency funded as part of the "COVID-19 - Health in common" initiative. It is carried out under the framework of the ARIACOV programme, which stands for "Support to the African Response to the COVID-19 epidemic"
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Local Ethics Committee for Biomedical Research of the University of Parakou in Benin under number: 0308/CLERB-UP/P/SP/R/SA.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos